Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Jul 30, 2018

SELL
$38.72 - $42.52 $10.5 Million - $11.5 Million
-269,986 Closed
0 $0
Q1 2018

May 07, 2018

SELL
$39.4 - $47.39 $4.98 Million - $5.99 Million
-126,399 Reduced 31.89%
269,986 $11.1 Million
Q4 2017

Feb 07, 2018

BUY
$37.27 - $43.02 $14.8 Million - $17.1 Million
396,385
396,385 $16.3 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Hood River Capital Management LLC Portfolio

Follow Hood River Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hood River Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hood River Capital Management LLC with notifications on news.